Carving Out Financial Success: The Power of Insurance Carve-Outs in a Private Plastic Surgery Practice.


Journal

Plastic and reconstructive surgery
ISSN: 1529-4242
Titre abrégé: Plast Reconstr Surg
Pays: United States
ID NLM: 1306050

Informations de publication

Date de publication:
01 Jul 2021
Historique:
entrez: 28 6 2021
pubmed: 29 6 2021
medline: 18 9 2021
Statut: ppublish

Résumé

Since the Patient Protection and Affordable Care Act was signed into law, there has been a push away from fee-for-service payment models. The rise of bundled payments has drastically impacted plastic surgeons' incomes, especially nonsalaried surgeons in private practice. As a result, physicians must now attempt to optimize contractual reimbursement agreements (carve-outs) with insurance providers. The aim of this article is to explain the economics behind negotiating carve-outs and to offer a how-to guide for plastic surgeons to use in such negotiations. Based on work relative value units, Medicare reimbursement, overhead expenses, physician workload, and desired income, the authors present an approach that allows surgeons to evaluate the reimbursement they receive for various procedures. The authors then review factors that influence whether a carve-out can be pursued. Finally, the authors consider relevant nuances of negotiating with insurance companies. Using tissue expander insertion (CPT 19357) as an example, the authors review the mathematics, thought process required, and necessary steps in determining whether a carve-out should be pursued. Strategies for negotiation with insurance companies were identified. The presented approach can be used to potentially negotiate a carve-out for any reconstructive procedure that meets appropriate financial criteria. Understanding practice costs will allow plastic surgeons to evaluate the true value of insurance reimbursements and determine whether a carve-out is worth pursuing. Plastic surgeons must be prepared to negotiate adequate reimbursement carve-outs whenever possible. Ultimately, by aligning the best quality patient care with insurance companies' financial motivations, plastic surgeons have the opportunity to improve reimbursement for some reconstructive procedures.

Sections du résumé

BACKGROUND BACKGROUND
Since the Patient Protection and Affordable Care Act was signed into law, there has been a push away from fee-for-service payment models. The rise of bundled payments has drastically impacted plastic surgeons' incomes, especially nonsalaried surgeons in private practice. As a result, physicians must now attempt to optimize contractual reimbursement agreements (carve-outs) with insurance providers. The aim of this article is to explain the economics behind negotiating carve-outs and to offer a how-to guide for plastic surgeons to use in such negotiations.
METHODS METHODS
Based on work relative value units, Medicare reimbursement, overhead expenses, physician workload, and desired income, the authors present an approach that allows surgeons to evaluate the reimbursement they receive for various procedures. The authors then review factors that influence whether a carve-out can be pursued. Finally, the authors consider relevant nuances of negotiating with insurance companies.
RESULTS RESULTS
Using tissue expander insertion (CPT 19357) as an example, the authors review the mathematics, thought process required, and necessary steps in determining whether a carve-out should be pursued. Strategies for negotiation with insurance companies were identified. The presented approach can be used to potentially negotiate a carve-out for any reconstructive procedure that meets appropriate financial criteria.
CONCLUSIONS CONCLUSIONS
Understanding practice costs will allow plastic surgeons to evaluate the true value of insurance reimbursements and determine whether a carve-out is worth pursuing. Plastic surgeons must be prepared to negotiate adequate reimbursement carve-outs whenever possible. Ultimately, by aligning the best quality patient care with insurance companies' financial motivations, plastic surgeons have the opportunity to improve reimbursement for some reconstructive procedures.

Identifiants

pubmed: 34181623
doi: 10.1097/PRS.0000000000008062
pii: 00006534-202107000-00040
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

239-246

Informations de copyright

Copyright © 2021 by the American Society of Plastic Surgeons.

Références

Chen JT, Israel JS, Poore SO, Rao VK. The Affordable Care Act: A primer for plastic surgeons. Plast Reconstr Surg. 2014;134:830e–837e.
Ganske I, Abbott MM, Meara J. Accountable care organizations: A primer for surgeons. Bull Am Coll Surg. 2011;96:27–35.
Schroeder SA, Frist W; National Commission on Physician Payment Reform. Phasing out fee-for-service payment. N Engl J Med. 2013;368:2029–2032.
Israel JS, Chen JT, Rao VK, Poore SO. Plastic surgeons’ perceptions of the Affordable Care Act: Results of a national survey. Plast Reconstr Surg Glob Open. 2015;3:e293.
Medicare.gov. What part A covers. Available at: https://www.medicare.gov/what-medicare-covers/part-a/what-part-a-covers.html . Accessed November 11, 2019.
Medicare.gov. What part B covers. Available at: https://www.medicare.gov/what-medicare-covers/part-b/what-part-b-covers.html . Accessed November 11, 2019.
Medicare.gov. Your Medicare coverage: Cosmetic surgery. Available at: https://www.medicare.gov/coverage/cosmetic-surgery.html . Accessed November 11, 2019.
Ly DP, Glied SA. The impact of managed care contracting on physicians. J Gen Intern Med. 2014;29:237–242.
Firouzbakht PK, Israel JS, Chen JT, Rao VK. Medicare for the plastic and reconstructive surgeon. Plast Reconstr Surg. 2018;142:568–576.
Salary.com. Surgeon - Plastic reconstructive salary in the United States.2019Available at: https://www.salary.com/research/salary/benchmark/surgeon-plastic-reconstructive-salary#experienceyear . Accessed November 11, 2019.
Kane L. Medscape plastic surgeon compensation report 2019. Available at: https://www.medscape.com/slideshow/2019-compensation-plastic-surgeon-6011345#2 . Accessed November 11, 2019.
Allied Physicians. Physician salary survey: Physician surveys. Available at: http://alliedphysicians.com/salary-surveys/physicians/ . Accessed November 11, 2019.
Wisniewski S. Report on Medical School Faculty Salaries 2009-20102011.Washington, DC: Association of American Medical Colleges;
Cano SJ, Klassen AF, Scott AM, Cordeiro PG, Pusic AL. The BREAST-Q: Further validation in independent clinical samples. Plast Reconstr Surg. 2012;129:293–302.
Coriddi M, Nadeau M, Taghizadeh M, Taylor A. Analysis of satisfaction and well-being following breast reduction using a validated survey instrument: The BREAST-Q. Plast Reconstr Surg. 2013;132:285–290.
Mundy LR, Homa K, Klassen AF, Pusic AL, Kerrigan CL. Understanding the health burden of macromastia: Normative data for the BREAST-Q Reduction Module. Plast Reconstr Surg. 2017;139:846e–853e.
Pusic AL, Klassen AF, Scott AM, Klok JA, Cordeiro PG, Cano SJ. Development of a new patient-reported outcome measure for breast surgery: The BREAST-Q. Plast Reconstr Surg. 2009;124:345–353.
Gerstle T, Hassanein AH, Eriksson E. iPad integration in plastic surgical training: Optimizing clinical efficiency, education, and compliance with the health insurance portability and accountability act. Plast Reconstr Surg. 2015;135:223e–225e.
American College of Surgeons Task Force. Position of the American College of Surgeons on restrictions on resident work hours. Bull Am Coll Surg. 2009;94:11–18.
Althausen PL, Shannon S, Owens B, et al. Impact of hospital-employed physician assistants on a level II community-based orthopaedic trauma system. J Orthop Trauma. 2013;27:e87–e91.
Bohm ER, Dunbar M, Pitman D, Rhule C, Araneta J. Experience with physician assistants in a Canadian arthroplasty program. Can J Surg. 2010;53:103–108.
Meyer SC, Miers LJ. Cardiovascular surgeon and acute care nurse practitioner: Collaboration on postoperative outcomes. AACN Clin Issues. 2005;16:149–158.
Wai PY, O’Hern T, Andersen DO, et al. Impact of business infrastructure on financial metrics in departments of surgery. Surgery. 2012;152:729–734; discussion 734–737.
CMS.gov. Physician fee schedule search. Available at: https://www.cms.gov/files/document/2020-physician-fee-schedule-guide.pdf . Accessed November 11, 2019.

Auteurs

Gabriel M Kind (GM)

From Kind Chang Plastic Surgery; the Department of Surgery, Division of Plastic and Reconstructive Surgery, University of California-San Francisco; the Division of Plastic Surgery, Michael E. DeBakey Department of Surgery, Baylor College of Medicine; the Division of Plastic Surgery, Department of Surgery, Texas Children's Hospital; PRMA Plastic Surgery; and the Department of Plastic Surgery, University of Texas Southwestern Medical Center.

Matthew J Davis (MJ)

From Kind Chang Plastic Surgery; the Department of Surgery, Division of Plastic and Reconstructive Surgery, University of California-San Francisco; the Division of Plastic Surgery, Michael E. DeBakey Department of Surgery, Baylor College of Medicine; the Division of Plastic Surgery, Department of Surgery, Texas Children's Hospital; PRMA Plastic Surgery; and the Department of Plastic Surgery, University of Texas Southwestern Medical Center.

Amjed Abu-Ghname (A)

From Kind Chang Plastic Surgery; the Department of Surgery, Division of Plastic and Reconstructive Surgery, University of California-San Francisco; the Division of Plastic Surgery, Michael E. DeBakey Department of Surgery, Baylor College of Medicine; the Division of Plastic Surgery, Department of Surgery, Texas Children's Hospital; PRMA Plastic Surgery; and the Department of Plastic Surgery, University of Texas Southwestern Medical Center.

Oscar Ochoa (O)

From Kind Chang Plastic Surgery; the Department of Surgery, Division of Plastic and Reconstructive Surgery, University of California-San Francisco; the Division of Plastic Surgery, Michael E. DeBakey Department of Surgery, Baylor College of Medicine; the Division of Plastic Surgery, Department of Surgery, Texas Children's Hospital; PRMA Plastic Surgery; and the Department of Plastic Surgery, University of Texas Southwestern Medical Center.

Ron Hoxworth (R)

From Kind Chang Plastic Surgery; the Department of Surgery, Division of Plastic and Reconstructive Surgery, University of California-San Francisco; the Division of Plastic Surgery, Michael E. DeBakey Department of Surgery, Baylor College of Medicine; the Division of Plastic Surgery, Department of Surgery, Texas Children's Hospital; PRMA Plastic Surgery; and the Department of Plastic Surgery, University of Texas Southwestern Medical Center.

Sebastian Winocour (S)

From Kind Chang Plastic Surgery; the Department of Surgery, Division of Plastic and Reconstructive Surgery, University of California-San Francisco; the Division of Plastic Surgery, Michael E. DeBakey Department of Surgery, Baylor College of Medicine; the Division of Plastic Surgery, Department of Surgery, Texas Children's Hospital; PRMA Plastic Surgery; and the Department of Plastic Surgery, University of Texas Southwestern Medical Center.

Marco Maricevich (M)

From Kind Chang Plastic Surgery; the Department of Surgery, Division of Plastic and Reconstructive Surgery, University of California-San Francisco; the Division of Plastic Surgery, Michael E. DeBakey Department of Surgery, Baylor College of Medicine; the Division of Plastic Surgery, Department of Surgery, Texas Children's Hospital; PRMA Plastic Surgery; and the Department of Plastic Surgery, University of Texas Southwestern Medical Center.

Minas Chrysopoulo (M)

From Kind Chang Plastic Surgery; the Department of Surgery, Division of Plastic and Reconstructive Surgery, University of California-San Francisco; the Division of Plastic Surgery, Michael E. DeBakey Department of Surgery, Baylor College of Medicine; the Division of Plastic Surgery, Department of Surgery, Texas Children's Hospital; PRMA Plastic Surgery; and the Department of Plastic Surgery, University of Texas Southwestern Medical Center.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH